Anti-CD19-CD22 antibody drug conjugate to reduce tumor recurrence in B-cell hematologic cancers.
CANCER RESEARCH（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined